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Abstract	During	biosynthesis	on	the	ribosome,	an	elongating	nascent	polypeptide	chain	can	begin	to	fold,	in	a	process	central	 to	all	 living	systems.	Detailed	structural	studies	of	co-translational	protein	folding	are	now	beginning	to	emerge;	such	studies	were	previously	 limited,	at	 least	 in	part,	by	the	 inherently	 dynamic	 nature	 of	 emerging	 nascent	 chains,	 which	 precluded	 most	 structural	techniques.	 Nuclear	 Magnetic	 Resonance	 (NMR)	 spectroscopy	 is	 able	 to	 provide	 atomic-resolution	 information	 for	 ribosome-nascent	 chain	 complexes	 (RNCs),	 but	 requires	 significant	quantities	 (≥10	 mg)	 of	 homogeneous,	 isotopically-labelled	 RNCs.	 Further	 challenges	 include	limited	 sample	 working	 concentration	 and	 stability	 of	 the	 RNC	 sample	 (which	 contribute	 to	weak	 NMR	 signals)	 and	 resonance	 broadening	 caused	 by	 attachment	 to	 the	 large	 (2.4	 MDa)	ribosomal	complex.	Here,	we	present	a	strategy	to	generate	isotopically-labelled	RNCs	in	E.	coli	that	are	suitable	for	NMR	studies.	Uniform	translational-arrest	of	the	nascent	chains	is	achieved	using	an	arrest	motif,	and	 isotopically-labelled	RNCs	are	produced	at	high	yield	using	high	cell	density	E.	coli	growth	conditions.	Homogeneous	RNCs	are	 isolated	by	combining	metal	affinity	chromatography	 to	 isolate	 ribosome-bound	 species	 with	 sucrose	 density	 centrifugation	 to	recover	 intact	70S	monosomes.	Sensitivity-optimised	NMR	spectroscopy	 is	 then	applied	 to	 the	RNCs,	 combined	with	 a	 suite	 of	 parallel	NMR	and	biochemical	 analyses	 to	 cross-validate	 their	integrity,	 including	 RNC-optimised	 NMR	 diffusion	 measurements	 to	 report	 on	 ribosome-attachment	 in	 situ.	 Comparative	 NMR	 studies	 of	 RNCs	 with	 the	 analogous	 isolated	 proteins	permit	a	high-resolution	description	of	the	structure	and	dynamics	of	a	nascent	chain	during	its	progressive	biosynthesis	on	the	ribosome.				
Introduction	An	emerging	nascent	polypeptide	chain	is	extruded	from	the	ribosome	from	its	N-	to	C-terminus	and	is	able	to	adopt	its	biologically	active	structure	in	a	co-translational	fashion1,	2.	This	process	has	been	explored	kinetically	through	biochemical	studies,	including	pulse-chase	investigations	that	are	typically	coupled	to	observations	of	proteolytic	cleavage3	or	disulphide	bond	detection4,	which	show	that	protein	folding	on	the	ribosome	can	be	coupled	to	translation	on	the	biological	timescale.	 A	 high	 resolution	 understanding	 of	 how	 emerging	 nascent	 chains	 may	 adopt	conformations	 on	 the	 ribosome,	 however,	 has	 been	 largely	 underpinned	 by	 biochemical	 and	biophysical	 experiments	 carried	 out	 on	 translational-arrested	 ribosome-nascent	 chain	complexes	 (RNCs).	 Key	 to	 these	 latter	 studies	 is	 the	 ability	 to	 achieve	 selective	 and	 uniform	translational	 arrest	 using	 peptidic	 motifs;	 these	 motifs	 directly	 interact	 with	 the	 ribosome5	during	biosynthesis	to	stably	retain	a	nascent	chain	of	uniform	length	relative	to	the	3’	truncated	non-stop	mRNA6,	7.	In	the	case	of	70S	ribosomes	from	E.	coli,	peptidic	motifs	derived	from	the	E.	
coli	 proteins	 TnaC8	 and	 SecM1,	 9-12	 have	 been	 successfully	 exploited	 to	 produce	 homogeneous	RNCs	by	generating	thermodynamic	snapshots	of	the	emerging	nascent	chain	at	different	stages	of	its	biosynthesis10.	While	the	conformational	preferences	of	an	emerging	nascent	chain	will	be	
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under	kinetic	control,	where	rates	of	translation	compete	with	rates	of	folding	the	use	of	stalled	RNCs	has	enabled	 important	advances	 in	our	understanding	of	 their	acquisition	of	biologically	active	 structure13,14.	 This	 has	 typically	 been	 reported	 using	 biochemical	 approaches	 including	antibody	 recognition	 studies15,	 16	 and	 limited	 proteolysis17	 in	 studies	 of	 several	 multi-domain	proteins18-21.	 FRET	 studies	 of	 RNCs	 have	 been	 particularly	 fruitful	 in	 exploring	 nascent	 chain	emergence	and	 folding,	highlighted	 in	 the	study	of	an	N-terminal	domain	of	HemK,	which	was	shown	 to	 sample	 a	 compact	 state	 prior	 to	 adopting	 its	 fold22,	 and	 the	 demonstration	 of	sequential	 formation	 of	 subdomains	within	 NBD1	 of	 the	multi-domain	 protein	 CFTR7.	 FRET23	has	also	been	central	to	examination	of	early	chain	compaction	within	the	exit	tunnel,	as	has	the	development	 of	 cysteine-mass	 tagging	 PEGylation	 experiments18;	 together	 data	 generated	 by	these	 techniques	 have	 suggested	 that	 nascent	 chains	 are	 able	 to	 form	 rudimentary	 structures	such	as	α-helices	and	β	turns23,	24	as	they	traverse	the	ribosomal	exit	tunnel.			 That	 differences	 exist	 between	 co-translational	 folding	 and	 the	 reversible	 folding	 of	isolated	 proteins	 was	 initially	 well-illustrated	 in	 the	 cases	 of	 firefly	 luciferase18	 and	 tailspike	protein19:	 as	 isolated	proteins,	 they	are	unable	 to	 fold	 reversibly	 from	a	 chemically	denatured	state,	yet	as	RNCs,	they	showed	the	capacity	to	adopt	native	structure	co-translationally	during	progressive	emergence	on	the	ribosome.	It	has	been	suggested	that	the	efficiency	of	folding	on	the	 ribosome	may	 in	part	be	 influenced	by	 the	 effects	 of	 the	 ribosomal	 surface25,	 26,	 for	which	marked	 differences	 in	 folding	 rates	 have	 been	 observed	 in	 optical	 tweezer	 experiments	 of	 T4	lysozyme	RNCs25.	In	addition,	the	distribution	of	synonymous	and	non-synonymous	codons21,	27	in	the	mRNA	sequence	alters	the	rate	of	nascent	chain	biosynthesis	and,	concomitantly,	the	rate	and	 efficiency	 of	 folding7,	 28,	 29.	 In	 addition,	 the	 emerging	 nascent	 chain	 encounters	 a	 range	 of	ribosome-associated	auxiliary	 factors	 in	 the	crowded	cellular	environment,	 the	most	pertinent	for	co-translational	folding	being	the	molecular	chaperone	trigger	factor4,	30,	31,	whose	proposed	interactions	are	both	nascent	chain	length-	and	sequence-dependent	and	likely	shape	the	folding	landscape	available	to	the	nascent	chain.		 Despite	 the	 possible	 influences	 that	 co-translational	 folding	 events	 may	 have	 in	promoting	 efficient	 folding,	 a	 structural	 understanding	of	 how	 this	 process	 is	 achieved	on	 the	ribosome	is	lacking.	Underpinned	by	comprehensive	studies	of	the	functional	ribosome	using	X-ray	 crystallography	 and	 cryo-EM9,	 32-37,	 high-resolution	 structural	 studies	 of	 RNCs	 using	 cryo-EM8,	 9,	 38	 and	 NMR	 spectroscopy10,	 39-41	 are	 beginning	 to	 provide	 more	 detailed	 structural	descriptions	 of	 the	 conformations	 sampled	 by	 ribosome-bound	 nascent	 chains.	 Cryo-EM	reconstructions	 of	 RNCs	 have	 in	 some	 cases,	 for	 example,	 revealed	 nascent	 chain	 compaction	and	α-helix	formation	within	the	ribosomal	exit	tunnel38	and,	more	recently,	the	formation	of	a	simple	tertiary	motif42.	The	steric	restrictions	imposed	by	the	ribosomal	exit	tunnel34,	however,	result	 in	 tertiary	structure	only	 forming	beyond	the	 tunnel	 in	 the	majority	of	cases,	where	 the	dynamic	 nature	 of	 the	 ribosome-bound	 nascent	 chain	 impedes	 its	 observation	 via	 cryo-EM.	 A	
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structural	 understanding	 of	 the	 nascent	 chain	 remains	 experimentally	 challenging	 due	 to	 its	inherently	dynamic	character	and	studies	of	such	conformations	are	only	possible	 through	the	use	 of	 NMR	 spectroscopy10,	 39,	 40,	 a	 technique	 uniquely	 poised	 to	 offer	 both	 structural	 and	dynamical	 information.	 Indeed,	 despite	 the	 large	 molecular	 weight	 (2.4	 MDa)	 of	 the	 70S	ribosome	 complex,	 which	 contributes	 to	 significant	 broadening	 of	 the	 majority	 of	 its	 NMR	signals43,	44,	ribosome-bound	nascent	chains	display	comparatively	sharp	and	intense	resonances	such	 that	 detailed	 systematic	 structural	 studies	 of	 nascent	 chain	 folding	 on	 the	 ribosome	 are	now	emerging1,	10,	39,	40.	These	have	been	made	possible	by	advances	in	preparative	biochemistry	methods	 for	 the	 production	 of	 large	 quantities	 of	 homogeneous	 RNCs.	 In	 vitro	 transcription-translation	 strategies9,	 39,	 but	 also	 the	 more	 recently	 developed	 in	 vivo	 approaches	 using	selective	and	uniform	translational	arrest,	have	enabled	the	production	of	 isotopically-labelled	RNCs	specifically	for	NMR	studies10,	45.		Much	 of	 our	 current	 understanding	 of	 co-translational	 folding	 has	 been	 derived	 from	biochemical	and	biophysical	studies	of	RNCs,	which	offer	the	advantage	over	NMR	studies	in	that	they	 can	 report	 on	 kinetic	 rates	 as	 monitored	 in	 real-time,	 however	 structural	 changes	 are	typically	inferred	from	single-site	fluorescence	probes	on	the	nascent	chain	or	through	nascent	chain	 interactions	 with	 reporter	 molecules.	 NMR	 spectroscopy	 of	 RNCs	 has,	 therefore,	 a	significant	 advantage	 in	 its	 capacity	 to	 directly	 report	 upon	 structure,	 but	 describing	 co-translational	 protein	 folding	 at	 a	 residue-specific	 level.	 Its	 capacity	 to	 report	 on	 the	 highly	dynamic	 nascent	 chain	 beyond	 the	 ribosomal	 tunnel	 means	 that	 it	 is	 uniquely	 positioned	 to	complement	structural	techniques	such	as	cryo	EM	to	generate	a	high-resolution	understanding	of	structure	formation	as	it	occurs	during	biosynthesis.	Here,	we	present	 an	 approach	 that	 can	be	used	 to	describe	 conformations	 adopted	by	nascent	chains	during	translation,	based	on	methods	used	in	our	laboratory	in	studies	of	over	50	nascent	chain	samples	of	varying	length	and	different	sequences;	our	studies	of	an	Ig-fold,1,	10,	39,	40,46	 and	of	 an	 intrinsically	disordered	polypeptide	 (alpha-synuclein47)	 have	been	of	 particular	value	 in	 developing	 our	 methodology.	 The	 protocol	 describes	 the	 in	 vivo	 production	 of	isotopically-labelled	RNCs,	a	biochemical	approach	 for	sample	characterisation	and	a	guide	 for	NMR	data	acquisition	and	 subsequent	analysis	 in	order	 to	describe	 conformations	adopted	by	nascent	 chains	 during	 translation.	 Rigorous	 approaches	 to	 monitor	 sample	 integrity	 are	 also	outlined.	 This	 protocol	 will	 serve	 as	 an	 essential	 foundation	 for	 detailed	 studies	 of	 co-translational	folding,	allowing	an	understanding	of	the	conformational	dynamics	of	a	ribosome-bound	nascent	chain,	and	serving	to	provide	molecular	restraints	for	molecular	models	at	atomic	resolution1.		
Development	of	the	Procedure	
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We	have	designed	an	approach	to	produce	homogeneous	and	isotopically-labelled	RNCs	
in	vivo	through	the	manipulation	of	E.	coli	growth	to	generate	large	quantities	of	translationally-active	ribosomes;	this	was	achieved	by	using	high-cell	density	growth	conditions	adapted	from	auto-induction	procedures48.	The	 isolation	of	 large	amounts	of	 translating	 ribosomes	 relies	on	well-established	 separation	 techniques--	 the	 sedimentation	 of	 ribosomal	 complexes	 using	sucrose	 density	 ultracentrifugation49.	 We	 further	 adapted	 this	 technique	 for	 selection	 and	purification	 of	 ribosome-bound	 nascent	 chains10	 at	 the	 high	 yields	 required	 for	 NMR	spectroscopy	 relative	 to	 other	 structural	 and	 biophysical	 techniques;.	 ~10	 mg	 of	 material	 is	required	 per	 NMR	 sample	 which	 is	 roughly	 2	 to	 3	 orders	 of	 magnitude	 greater	 than	 that	required	 for	 cryo-EM.	 	 We	 generate	 RNCs	 of	 different	 nascent	 chain	 lengths	 by	 varying	 the	distance	 separating	 the	 protein	 of	 interest	 from	 the	 ribosome’s	 peptidyl	 transferase	 centre	(PTC),	 thereby	producing	successive	snapshots	along	 the	co-translational	 folding	pathway	and	enabling	 us	 to	 monitor	 both	 unfolded	 and	 folded	 conformations	 using	 equilibrium	measurements.	 By	 evaluating	 variables	 including	 the	 sequence	 determinants	 and	 polypeptide	chain	 length-dependent	 acquisition	 of	 structure	 during	 biosynthesis,	 we	 are	 developing	structural	models	of	co-translational	protein	folding.		 NMR	 studies	 of	 RNCs	 are	 challenging	 for	 reasons	 that	 include	 the	 high	 viscosity	 of	ribosomal	solutions	(with	ideal	working	concentrations	for	NMR	of	~10	µM,	24	mg/mL),	but	a	significant	 limitation	 results	 from	 the	 inherent	 instability	 of	 the	 ribosomal	 complex,	 which	 is	prone	to	degradation	over	extended	periods	of	time.	Ribosome-bound	nascent	chains	can	also	be	released	from	the	ribosomal	particle	through	mechanisms	that	include	the	overcoming	of	SecM	stalling	 via	 spontaneous	 translocation50,	 51	 or	 by	 the	 action	 of	 trace	 amounts	 of	 proteases.	We	have	 therefore	 adapted	 translational	 diffusion	 measurements	 from	 our	 NMR	 studies	 of	ribosomes43	 to	 carefully	 monitor	 nascent	 chain	 integrity	 during	 NMR	 acquisition,	 and	complemented	 these	 with	 an	 orthogonal	 approach	 using	 biochemical	 assays	 to	 validate	 our	observations.			 The	 NMR	 strategy	 presented	 here	 should	 guide	 the	 reader	 towards	 the	 production	 of	RNCs	 and	 detailed	 structural	 studies	 of	 co-translational	 folding	 events	 as	 they	 occur	 during	biosynthesis	on	 the	ribosome,	as	we	have	undertaken	 for	FLN51,	 10,	 40,	 52	and	alpha-synuclein47.	Combining	 RNCs	 with	 comparative	 studies	 of	 the	 analogous	 isolated	 proteins	 provides	 the	means	to	understand	the	manner	in	which	the	ribosome	modulates	folding	within	living	systems	in	conjunction	with	the	array	of	cellular	factors	that	are	distinct	from	studies	of	protein	folding	in	bulk	solution.		
Overview	of	the	Procedure	Here,	 we	 describe	 the	main	 steps	 involved	 in	 sample	 production	 and	 data	 analysis	 to	report	on	structural	conformations	populated	by	nascent	chains	bound	to	the	ribosome	(Fig.	1).	
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DNA	 constructs	 are	 designed	 to	 generate	 RNCs	 of	 the	 protein	 of	 interest	 using	 an	 expression	vector	 with	 a	 translational	 arrest	 motif,	 e.g.	 a	 pLDC-17	 vector10	 (Fig.	 1a)	 and	 an	 N-terminal	purification	tag	e.g.	a	His	tag.	For	the	production	of	isotopically-labelled	RNCs	(Fig.	1a),	high-cell	density	 cultures	 of	 E.	 coli	 are	 grown	 (typically	 0.5-2	 L)	 to	 which	 isotopes	 are	 added	 at	 the	induction	 of	 protein	 expression10,	 in	 order	 to	 confine	 labelling	 to	 the	 nascent	 chain.	 For	purification	of	the	RNCs	(Fig.	1a),	the	E.	coli	cells	are	lysed	and	the	RNCs	are	recovered	using	a	combination	of	purification	methods	involving,	for	example,	metal	affinity	chromatography	to	an	N-terminal	 tag	(for	His-tagged	RNCs)	and	sucrose	density	centrifugation	(Fig.	2a).	Biochemical	analyses	of	the	purified	RNCs	using	SDS-PAGE	and	western	blot	analyses	(Fig.	1b	and	Fig.	2b-d)	evaluate	the	homogeneity	and	integrity	of	the	samples.		NMR	experiments	on	RNCs	(Fig.	1c)	are	typically	performed	using	sample	concentrations	close	to	10	µM,	as	the	70S	complexes	are	less	stable	at	higher	concentrations	and	the	associated	increases	 in	 sample	 viscosity	 impacts	 on	 the	 observable	NMR	 signal.	A	 temperature	 is	 chosen	that	is	suitable	for	the	system	in	question,	for	example,	reduced	temperatures	(e.g.	277	K,	283	K)	favour	 sample	 stability,	 and	 are	 desirable	 for	 the	 study	 of	 disordered	 conformations	 as	decreased	amide/water	proton	exchange	effects	result	in	increased	signal	intensity53.	Reducing	the	temperature	also	minimizes	the	background	signal	contribution	from	the	globular	ribosomal	protein,	 bL12.	 By	 contrast,	 higher	 temperatures	 (e.g.	 298	K)	 have	 the	 effect	 of	 decreasing	 the	correlation	 times	 of	 folded	 proteins	 and	 therefore	 improving	 their	 NMR	 observability,	 but	increasing	 temperatures	 to	 310	K	 results	 in	 severe	 ribosomal	 degradation	 over	 short	 periods	(minutes-hours).	 The	 exact	 parameters	 chosen	 for	 data	 acquisition	 therefore	 require	consideration,	as	further	outlined	in	Box	1,	to	maximise	the	observable	signal	and	the	quality	of	data.	Typically	for	RNCs,	heteronuclear	experiments	are	recorded	in	an	interleaved	manner	with	translational	 diffusion	NMR	 experiments	 that	 report	 specifically	 on	 sample	 integrity	 (Fig.	 1c).	Indeed,	RNC	 lifetimes	 can	 vary	 considerably	 depending	 on	 their	 structural	 properties	 and	 the	temperature	at	which	they	are	recorded	(e.g.	on	the	order	of	days	at	277	K,	but	only	up	to	~30	h	at	 298	 K).	 Nascent	 chain	 degradation	 can	 significantly	 complicate	 the	 interpretation	 of	 RNC	spectra	as	the	presence	of	a	comparatively	small	population	of	released	nascent	chain	can	give	rise	to	sharp	and	intense	resonances	due	to	its	much	shorter	correlation	time39.	The	quality	control	analysis	(Fig.	1c)	of	 the	ribosomal	complex	during	NMR	acquisition	involves	monitoring	 resonances	 corresponding	 to	 70S	 ribosomal	 proteins	 in	 1D	 experiments,	and	those	corresponding	to	the	nascent	chain	in	2D	experiments.	NMR	signals	can	be	monitored	over	time,	where	typically	an	increase	in	intensity	is	 interpreted	as	nascent	chain	release	from	the	 ribosome,	 (which	 can	 be	 rationalised	 by	 the	 shortened	 correlation	 time	 that	 would	 be	anticipated	 for	 a	 smaller	 species).	 Additionally,	 measurements	 of	 the	 translational	 diffusion	coefficient,	D,	by	NMR	also	exploit	the	 large	difference	in	D	between	intact	RNCs	and	degraded	ribosome	 particles	 or	 released	 nascent	 chains	 (e.g.	 at	 298	 K,	 D	 =	 2.0	 ±	 0.3x10-11	 m2s-1	 for	 a	
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ribosome-bound	 nascent	 chain	 and	 in	 our	 system	 D=1.3x10-10	 m2s-1	 for	 isolated	 or	 released	FLN5).	Thus,	 to	evaluate	the	 integrity	of	 the	70S	ribosome,	a	combination	of	 1H	1D	acquisition	and	1H	STE	translational	diffusion	experiments	(Fig.	3b,	c)	 is	used;	the	resonances	observed	in	the	 methyl	 region	 of	 the	 1H	 spectrum	 (0.7-1	 p.p.m.	 in	 the	 1H	 dimension,	 Fig.	 3b)	 originate	predominantly	 from	the	 labile	 ribosomal	bL12	protein54-56	and	can	be	used	as	an	approximate	measure	 of	 overall	 ribosomal	 integrity.	 Measurement	 of	 nascent	 chain	 attachment	 to	 the	ribosome	 is,	 however,	 essential,	 and	 15N	XSTE	or	 13C-edited	diffusion	 experiments	 are	used	 to	directly	 probe	 the	 nascent	 chain.	 In	 cases,	 however	where	 the	 nascent	 chain	may	 give	 rise	 to	NMR	signals	too	weak	for	diffusion	measurements	to	be	recorded	within	a	suitable	timeframe,	changes	 in	 the	 average	 2D	 intensities	 of	 the	 nascent	 chain	 can	 be	 used	 to	 monitor	 sample	stability.		In	 parallel	 with	 NMR	 experiments,	 samples	 of	 the	 RNC	 collected	 throughout	 NMR	acquisition	 are	 also	 probed	 using	 a	western	 blot	 to	 evaluate	 the	 nascent	 chain	 integrity	 over	time,	using	nascent	chain-specific	antibodies	against	the	N-terminus	(e.g.	anti-His	tag	antibody)	or	 the	 C-terminus	 (e.g.	 SecM	 stalling	 sequence).	 Ribosome-bound	 nascent	 chains	 typically	migrate	on	SDS-PAGE	with	an	additional	17-20	kDa	band-shift	 relative	 to	 that	of	 the	expected	molecular	mass	 of	 the	nascent	 chain;	 this	 is	 caused	by	 the	 presence	 of	 a	 P-site	 peptidyl	 tRNA	which	 is	 covalently	 linked	 to	a	 stalled	nascent	chain	 (Fig.	2c).	To	distinguish	 intact	RNCs	 from	those	 that	have	been	 compromised	by	nascent	 chain	 release,	we	 carry	out	polyacrylamide	gel	electrophoresis	using	low	pH	conditions	that	preserve	the	nascent	chain-tRNA	ester	bond.	With	these	 tools	 in	 hand,	 we	 are	 able	 to	 confidently	 report	 spectra	 of	 intact	 RNCs	 for	 structural	analysis,	 including	 detailed	 analyses	 of	 resonance	 intensities	 and	 linewidths,	 to	 explore	 the	relaxation	 properties	 and	 mobility	 of	 the	 nascent	 chain.	 Together,	 these	 studies	 are	 used	 to	describe	differences	between	folding	in	bulk	solution	and	on	the	ribosome.	
	
Advantages	and	Limitations		Our	 protocol	 presents	 a	 versatile	 in	 vivo	 approach	 using	 E.	 coli	 for	 the	 production	 of	significant	 quantities	 of	 homogeneous	 RNCs,	 which	 can	 be	 adapted	 to	 incorporate	 isotopic	labelling	 schemes	as	necessary	 for	 studies	using	NMR	spectroscopy.	The	 capacity	 to	 exploit	E.	
coli	 in	 this	 manner	 enables	 the	 production	 of	 uniformly-arrested	 RNCs	 comparable	 to	 those	produced	 using	 in	 vitro	 translation	 methods,	 using	 routine	 biochemical	 reagents,	 and	 at	 a	relatively	 low	 cost.	 	While	 the	 use	 of	 stable	 isotopes	 for	 nascent	 chain	 labelling	 introduces	 a	significant	cost,	it	is	arguably,	a	reasonable	compromise	for	the	rich,	residue-specific	information	that	can	be	derived	from	a	single	RNC	spectrum.	An	 important	 consideration,	 however,	 in	 using	 an	 in	 vivo-based	 approach	 for	 isotopic	labelling	of	RNCs	is	the	extent	to	which	the	labelling	is	confined	to	the	nascent	chain.		Continuous	ribosome	 biogenesis	 can	 result	 in	 background	 70S	 ribosome	 labelling,	 which	 gives	 rise	 to	
		 8	
resonances	that	correspond	to	the	bL12	ribosomal	stalk	observable	in	2D	correlation	spectra43	alongside	labelled	nascent	chains.	Typically	however,	the	high	cell	density	conditions	during	the	induction	 of	 expression	 restricts	 cell	 growth	 (and	 thus	 ribosome	 biogenesis),	 and	 the	 use	 of	rifampicin,	 an	 inhibitor	 of	 the	 bacterial	 host	 DNA	 polymerase,	 reduces	 the	 extent	 of	 bL12	isotopic	 labelling	 (by	 an	 additional	 ~10%	 in	 our	 hands).	 	 Our	 protocol	 also	 describes	 NMR	measurements	(step	24)	in	order	to	quantify	ribosome	background	labelling	in	samples	that	are	uniformly	15N	and/or	13C-labelled.		The	procedure	has	been	designed	 to	enable	RNCs	 to	be	produced	 in	a	 straightforward	manner,	however	the	most	significant	challenges	arise	from	the	inherent	complexities	presented	by	 the	 samples	 themselves	 during	 NMR	 studies.	 Notably,	 these	 include	 the	 low	 maximum	achievable	 RNC	 concentrations	 and	 their	 high	molecular	weight,	 the	 necessity	 for	 continuous	assessment	 of	 the	 sample’s	 integrity	 and	 the	 physical	 properties	 of	 the	 nascent	 chains	themselves.	 This	 prompts	 the	 need	 for	 a	 careful	 choice	 of	 nascent	 chain	 system	 (see	
Experimental	 Design)	 as	 well	 as	 NMR	 experimental	 design	 (Box	 1),	 and	 complementary	comparative	studies	with	the	isolated	protein.	We	anticipate	that	the	continuous	development	of	NMR	 strategies	 to	 enhance	 sensitivity,	 as	well	 as	 the	molecular	 biology	 of	 RNCs	will	 improve	further	the	capacity	to	study	co-translational	folding	in	this	manner.		
	
Experimental	Design	
Choosing	a	nascent	chain	system	to	study.	For	NMR	studies	of	RNCs,	a	key	factor	is	the	choice	 of	 the	 nascent	 polypeptide	 to	 investigate,	which	 is	 strongly	 influenced	 by	 the	 dynamic	properties	of	 the	nascent	chain	and	 its	 interactions	with	 the	ribosome.	Relative	 to	 the	 isolated	polypeptide	 in	 bulk	 solution,	 the	 ribosome-attached	 nascent	 chain	 has	 decreased	 motional	properties,	which	result	in	a	reduction	in	its	NMR	signal,	and	which	can	be	diminished	further	by	interactions	 between	 the	 nascent	 chain	 and	 the	 ribosomal	 surface,	 or	 by	 possible	 intra-chain	interactions.	 As	 NMR	 has	 the	 capacity	 to	 report	 on	 transient	 and/or	 weak	 interactions,	 any	significant	affinity	between	the	nascent	chain	of	interest	and	the	ribosomal	surface	manifests	as	resonance	broadening	and/or	changes	in	chemical	shift.	Our	protocol	has,	to	date,	been	applied	to	polypeptides	that	 inherently	give	rise	to	strong	NMR	signals	(i.e.	proteins	of	small	size	(<30	kDa)	and/or	of	disordered	nature)	and	 to	 those	 that	 that	 show	a	high	spectral	quality	 in	both	their	natively	folded	and	unfolded	forms	even	in	the	presence	of	70S	ribosomes	(Supplementary	Fig.	 1).	 A	 characterisation	 of	 the	 polypeptide	 of	 interest	 in	 isolation,	 in	 both	 its	 folded	 and	unfolded	forms	(achieved	e.g.	by	mutation	or	C-terminal	truncation),	and	in	the	presence	of	70S	ribosomes,	is	instructive	of	a	suitable	nascent	chain	choice	for	NMR	investigation;	it	also	forms	an	important	basis	for	comparative	analysis	relative	to	RNCs.	In	addition,	 it	 is	advantageous	to	choose	 a	 nascent	 chain	 system	where	 the	 polypeptide	 has	 biochemical	 properties	 that	 can	 be	evaluated.	 A	 range	 of	 biochemical	 and	 biophysical	 strategies	 have	 been	 used	 to	 characterise	
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ribosome-nascent	 chain	 complexes	 (e.g.	 enzymatic	 activity14,	 antibody	 recognition15,	 16,	 limited	proteolysis17,	PEGylation1,	 57),	as	well	as	 to	consider	 the	unique	 influence	of	 the	cellular	milieu	during	biosynthesis31,	58,	59.		The	use	of	combined	approaches	permits	potential	corroboration	of	the	high-resolution	NMR	studies	of	RNCs	with	co-translational	events	as	they	take	place	within	the	cell.		 Choice	of	isotopic	labelling	scheme.	The	choice	of	a	suitable	isotopic	labelling	scheme	constitutes	an	important	part	of	the	experimental	design	to	ensure	optimal	observability	of	the	nascent	 chain,	 as	 shown	 in	 our	 studies	 of	 FLN5	RNCs1,	 10,	 39,	 40,	 60.	For	 the	 study	 of	 disordered	conformations,	15N	labelling	can	take	advantage	of	the	large	dispersion	in	the	15N	dimension,	as	its	chemical	shift	 is	particularly	sensitive	to	 the	 local	amino	acid	sequence	rather	than	tertiary	structure.	 15N	 spectra	 therefore	 typically	 resolve	 a	 larger	 number	 of	 resonances	 arising	 from	disordered	states	as	compared	to	other	heteronuclei.	In	the	study	of	globular	states,	13C	labelling	can	 typically	 provide	 the	 more	 sensitive	 probes	 needed	 to	 characterise	 the	 conformations	present,	in	particular	the	formation	of	stable	tertiary	structure.	Observation	of	NMR	spectra	for	globular	nascent	chains	however,	present	additional	challenges	through	reduced	flexibility	and	proximity	 to	 the	 ribosomal	 particle10.	 To	 overcome	 unfavourable	 relaxation	 properties	 that	result	 in	 weak	 NMR	 signals	 in	 heteronuclear	 correlation	 spectra,	 selective	 methyl	 side-chain	labelling	of	 the	nascent	chain	combined	with	perdeuteration	(achievable	 for	 the	side	chains	of	Ile,	 Leu,	 Val,	 Ala,	 Met,	 Thr	 61,	 62;	 e.g.	 [U-2H];	 Ileδ1-[13CH3])	 offers	 vast	 enhancements	 in	 NMR	sensitivity63,	especially	when	paired	with	the	methyl-TROSY	effect	 inherent	to	the	HMQC	pulse	sequence.	 With	 the	 increasing	 expense	 associated	 with	 perdeuteration	 and	 selective	 13CH3	isotopic	labelling,	the	production	of	1H-15N	labelled	RNCs	would	be	a	recommended	first	step	to	initially	 evaluate	 an	 RNC	 system	 prior	 to	 introducing	 the	 more	 involved	 selective	 labelling	approaches.		
	
MATERIALS	
Reagents	CRITICAL:	 All	 reagents	 should	 be	 sourced	 at	 the	 highest	 possible	 grade.	 Unless	 otherwise	indicated,	most	routine	biochemical	reagents	can	be	sourced	from	the	user’s	preferred	supplier.	·		E.	coli	expression	vector	for	the	RNC	of	interest	(user	generated)	·		15NH4Cl	(98	atom	%	15N)	(sourced	from	e.g.	Isotec,	Cambridge	Isotope	Laboratories)	·		Appropriate	precursors	for	selective	methyl	labelling	(e.g.	2-Ketobutyric	acid-4-13C	sodium					salt	hydrate	for	Ile	labelling)			(sourced	from	e.g.	Isotec,	Cambridge	Isotope	Laboratories)	·		Antibiotics	(e.g.	ampicillin)	·		BL21	(DE3)	E.	coli	(e.g.	Novagen,	cat.	no.	230132)	·		BME	vitamins	100x	(Sigma-Aldrich	cat.	no.	B6891)	·		CaCl2	·		Deuterated	glucose	(D-Glucose-1,2,3,4,5,6,6-d7)	(e.g.	Sigma	Isotec,	cat.	no.	552003)	·		Deuterium	oxide	(D2O)	(99.8	atom	%	D)	(e.g.	Sigma	Isotec,	cat.	no.	617385)	·		D-Glucose	
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·		Isopropyl	β-D-1-thiogalactopyranoside	(IPTG)	·		KH2PO4	·		L-aspartic	acid		·		MgSO4		·		NaCl	·		Na2HPO4	·		Na2SO4	·		Rifampicin	·		Trace	metals:	CoCl2,	CuCl2,	NiCl2,	Na2SeO3,	Na2MoO4,	H3BO3,	ZnSO4,	MnCl2,	FeCl2	·		Yeast	nitrogen	base	(e.g.	Difco,	cat.	no.	233520)	·		Adenosine	Triphosphate	(ATP)	·		2-Mercaptoethanol	(BME)	·		4-(2-Hydroxyethyl)-1-piperazineethanesulfonic	acid-d18	(HEPES-d18)	(98	atom	%	D)	(sourced	from	e.g.	Isotec,	Cambridge	Isotope	Laboratories)	·		4,4-dimethyl-4-silapentane-1-sulfonic	acid	(DSS)	·		Bradford’s	Reagent		·		EDTA-free	protease	inhibitor	cocktail	tablets	(e.g.	cOmplete,	Mini,	EDTA-free	Protease	Inhibitor	Cocktail	Tablets,	Roche	cat.	no.	04	693	159	001)	·		Ethylenediaminetetraacetic	acid	(EDTA)	·		HEPES	·		Imidazole	·		Lysozyme	·		Magnesium	acetate	·		MgCl2	·		Potassium	acetate	·		DNase	I	(RNase	free)	·		Ultra	pure	sucrose	(e.g.	UltraPure	Sucrose,	Invitrogen	cat.	no.	15503-022)	·		Metal	affinity	resin	(e.g	Ni2+)	·		10,	12	or	15%	(w/v)	Bis-Tris	polyacrylamide	gel	(e.g.	Invitrogen	or	hand-cast)	·		MOPS	running	buffer	(e.g.	Invitrogen	cat.	no	NP0001)		·		Silver	staining	kit	·		Bis-Tris	·		Bromophenol	Blue	·		Dithiothreitol	(DTT)	·		Glycerol	·		Sodium	Dodecyl	Sulphate	(SDS)	·		Molecular	weight	marker	·		RNC	specific	antibodies	(e.g.	anti-His,	anti-SecM)		·		Blocking	reagents	(e.g.	skim	milk	powder)		·		Nitrocellulose	membrane	·		Enhanced	chemilluminescence	(ECL)	reagents		·		Glycine	·		Methanol	·		RNase	A		·		Sodium	dodecyl	sulphate	(SDS)	·		Tris-Base	·		Tween-20		·		Western	blot	molecular	weight	marker		
Equipment	
• Centrifuge(s)	capable	of	speeds	of	4,000	x	g,	and	18,000	x	g	
• Density	gradient	fractionation	system	for	pouring	and	fractionation	of	sucrose	gradients	(e.g.	Teledyne	Isco	Foxy	Jr	Fraction	Collector	coupled	a	pump	e.g.	Watson	Marlow	313S	pump)	
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• French	Press	or	equivalent	high	pressure	cellular	disruption	equipment	
• Software	for	NMR	data	processing,	e.g.	NMRPipe64	and	further	analysis,	such	as	Sparky	3.115	(T.	D.	Goddard	and	D.	G.	Kneller,	SPARKY	3,	University	of	California,	San	Francisco)	or	CcpNmr	Analysis	v.2.24165.		
• Software	for	statistical	analysis	and	data	visualization,	eg	MATLAB	R2014a	(MATLAB	and	Statistics	Toolbox	Release	2012b,	The	MathWorks,	Inc.,	Natick,	Massachusetts,	United	States)	or	Mathematica	Wolfram	(Wolfram	Research,	Inc.,	Mathematica,	Version	10.4,	Champaign,	IL	(2016))	
• Ultracentrifuge(s)	equipped	with	suitable	rotors	(e.g	Type45	Ti,	SW28	(Beckman))	
• NMR	spectrometer.	As	sensitivity	is	a	major	limiting	factor,	a	cryogenic	probehead	is	essential	and	a	magnetic	field	strength	corresponding	to	a	1H	frequency	≥700	MHz	is	recommended	(e.g.	Bruker	Avance	III)	
• NMR	tubes	5	mm	D2O-matched	Shigemi	tubes	(e.g.	Bruker,	BMS-005B)		REAGENT	SETUP	
100%	trace	metals:	 (2	mM	CoCl2,	2	mM	CuCl2,	2	mM	NiCl2,	2	mM	Na2SeO3,	2	mM	Na2MoO4,	2	mM	H3BO3,	1	mM	ZnSO4,	1	mM	MnCl2,	20	mM	CaCl2,	50	mM	FeCl3)	Prepare	a	50	mL	solution	by	adding	100	µL	1	M	CoCl2,	100	µL	1	M	CuCl2,	100	µL	1	M	NiCl2,	100	µL	1	M	Na2SeO3,	100	µL	1M	Na2MoO4,	100	µL	1	M	H3BO3,	50	µL	1	M	ZnSO4,	50	µL	1	M	MnCl2,	1	mL	1	M	CaCl2,	2.5	mL	1	M	FeCl3	to	H2O	(or	D2O).		Store	at	room	temperature	(stable	for	months).	
	
MDG	 medium:	 For	 the	 production	 of	 ribosomes,	 adapted	 from48.	 Prepare	 MDG	 for	 uniform	labelling	(step	3A(i))	in	H2O.	For	perdeuteration	(Procedure	step	3B),	prepare	all	components	in	deuterium	 oxide.	 	 For	 selective	methyl	 labelling	 (steps	 3B(i)-(iii)),	 use	 deuterated	 glucose,	 D-Glucose-1,2,3,4,5,6,6-d7		instead	of	D-Glucose	as	specified.	Filter	sterilise	all	stock	solutions	prior	to	use	and	store	at	room	temperature	(stable	for	months).	Component	 Amount	per	L	 Final	concentration	20%	 (w/v)	 D-Glucose	 (or	 D-Glucose-1,2,3,4,5,6,6-d7)	
10	mL	 2	g/L	
1	M	MgSO4	 2	mL		 2	mM	Trace	 metals	(100%)	 200	µL	 0.02%	1	M	Na2HPO4	 25	mL	 25	mM	1	M	KH2PO4	 25	mL	 25	mM	20%	(w/v)	NH4Cl	 5	mL	 1	g/L	1	M	Na2SO4	 5	mL	 5	mM	D2O	(or	dH2O)	 928	mL	 	
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EM9	medium.	 For	 expression	 of	 RNCs,	 adapted	 from66.	 For	 selective	 isotopic	 labelling	 of	 the	nascent	chain	(step	3A(iii)),	use	15N	NH4Cl	(15N	labelling)	or	13C	glucose	(13C	labelling)	as	desired.	For	selective	methyl	labelling	(step	3B(iv)),	use	D-Glucose-1,2,3,4,5,6,6-d7	instead	of	D-Glucose.		For	 perdeuteration	 (Procedure	 step	 3B),	 prepare	 all	 components	 in	 deuterium	 oxide.	 Filter	sterilise	all	stock	solutions	prior	to	use	and	store	at	room	temperature	(stable	for	months).		Compound	 Amount	 Final	concentration	20%	 (w/v)	 D-Glucose	(or	 13C-Glucose	 or	Glucose-1,2,3,4,5,6,6-d7)	 10	mL	 2	g	/	L	1	M	MgSO4	 2.5	mL	 2.5	mM	Trace	metals	(100%)	 125	µL	 0.0125%	(w/v)	70	g/L	Na2HPO4	 100	mL	 7	g/L	34	g/L	KH2PO4	 100	mL	 3.4	g/L	5.8	g/L	NaCl	 100	mL	 0.58	g/L	20%	 (w/v)	 NH4Cl	 (or	15N	NH4Cl)	 5	mL	 1	g/L	1	M	CaCl2	 200	µL	 0.2	mM	Yeast	nitrogen	base	 0.8	g	 0.8	g/L	H2O	(or	D2O)	 682	mL	 		
	
EM9	salts.	Prepare	a	100	mL	solution	by	adding	10	mL	70	g/L	Na2HPO4,	10	mL	34	g/L	KH2PO4	and	10	mL	5.8	g/L	NaCl	into	H2O.	
Lysis	buffer.	1	M	KOAc,	50	mM	HEPES,	12	mM	MgOAc,	5	mM	EDTA,	5	mM	ATP,	2	mM	BME,	1	mg/mL	lysozyme,	and	DNase	I,	protease	inhibitors	(as	per	manufacturer’s	instructions),	pH	7.5.	Prepare	a	100	mL	solution	by	adding	20	mL	5	M	KOAc,,	10	mL	0.5	M	Hepes,	4.8	mL	0.25	M	MgOAc,	1	mL	0.5	M	EDTA,	250	µg	ATP,	78	µL	BME,	100	mg	lysozyme,	and	traces	of	DNase	I	into	H2O.	pH	the	solution	using	NaOH.	Filter	sterilise	and	chill	prior	to	use.	
Resuspension	Buffer.1	M	KOAc,	50	mM	HEPES,	12	mM	MgOAc,	5	mM	EDTA,	5	mM	ATP,	2	mM	BME,	pH	7.5.	Prepare	a	100	mL	solution	by	adding	20	mL	5	M	KOAc,,	10	mL	0.5	M	Hepes,	4.8	mL	0.25	M	MgOAc,	1	mL	0.5	M	EDTA,	250	µg	ATP	and	78	µL	BME	into	H2O.	pH	the	solution	using	NaOH.	Filter	sterilise	and	chill	prior	to	use.	
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Washing	buffer.	500	mM	KOAc,	50	mM	HEPES,	6	mM	MgOAc,	2	mM	BME,	pH	7.5.	Prepare	a	500	mL	solution	by	adding	50	mL	5	M	KOAc,,	50	mL	0.5	M	Hepes,	12	mL	0.25	M	MgOAc	and	390	µL	BME	into	H2O.	pH	the	solution	using	NaOH.	Filter	sterilise	and	chill	prior	to	use.	
Elution	buffer.	500	mM	KOAc,	50	mM	HEPES,	6	mM	MgOAc,	150	mM	imidazole,	2	mM	BME,	pH	7.5.	Prepare	a	250	mL	solution	by	adding	25	mL	5	M	KOAc,,	25	mL	0.5	M	Hepes,	6	mL	0.25	M	MgOAc,	15	mL	2.5	M	imidazole	and	195	µL	BME	into	H2O.	pH	the	solution	using	HCl.	Filter	sterilise	and	chill	prior	to	use.	
Sucrose	buffers.	Two	stock	solutions	of	35%	and	10%	(w/v)	sucrose	in	1	M	KOAc,	50	mM	HEPES,	12	mM	MgOAc,	5	mM	EDTA,	2	mM	BME,	0.1/100	mL	protease	inhibitor	tablet,	pH	7.5.	Prepare	for	each	a	500	mL	solution	by	adding	175	g	(or	50	g)	of	sucrose,	100	mL	5	M	KOAc,,	50	mL	0.5	M	Hepes,	24	mL	0.25	M	MgOAc,	5	mL	0.5	M	EDTA,	390	µL	BME	and	0.5	protease	inhibitor	tablet	into	H2O.	pH	the	solution	using	NaOH.	Filter	sterilise	and	chill	prior	to	use.	
Tico	buffer.	30	mM	NH4Cl,	10	mM	HEPES	(or	deuterated	HEPES-D12),	12	mM	MgCl2,	1	mM	EDTA,	2	mM	BME,	0.1/100	mL	protease	inhibitor	tablet,	pH	7.5.	Prepare	a	100	mL	solution	by	adding	2	mL	of	0.5	M	Hepes,	6	mL	0.5	M	NH4Cl,	2.4	mL	0.5	M	MgCl2,	0.2	mL	0.5	M	EDTA,	156	µL	BME	and	0.1	protease	inhibitor	tablet	into	H2O.	pH	the	solution	using	NaOH.	Filter	sterilise	and	chill	prior	to	use.	
Low	pH	loading	dye.	Prepare	20	mL	as	tabulated	below.	Aliquot	into	1	mL	aliquots	and	store	at	-20°C	(stable	for	years).	Compound	 Amount	 Concentration	Glycerol	 	 30%	(v/v)	Bis-Tris	pH	5.7	 	 0.25	M	Bromophenol	Blue	 	 0.04%	(w/v)	DTT	 	 0.8%	(w/v)	SDS	 	 8%	(w/v)		 	 		 	 		
	
	
PROCEDURE	
Generation	of	isotopically-labelled	RNCs	TIMING		2	weeks	–	1	month	1. Using	 standard	 molecular	 biology	 techniques,	 introduce	 the	 gene	 coding	 for	 the	polypeptide	 of	 interest	 together	 with	 the	 SecM	 stalling	 motif	 (150-FSTPVWISQAQGIRAGP-166;	SecM	numbering12)	 into	an	E.	coli	expression	vector	with	a	suitable	N-terminal	purification	tag	as	desired.		2. Transform	the	DNA	construct	into	BL21(DE3)	E.	coli,	and	use	a	single	colony	to	inoculate	3	mL	of	LB	media	with	antibiotics.	Incubate	the	cells	at	37°C	and	180	rpm	for	12	h.		
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3. Depending	on	 the	 labelling	strategy	selected	 for	a	given	nascent	chain	system	(refer	 to	
Experimental	Design),	isotopically-label	RNCs	in	vivo	using	E.	coli	according	to	Option	(A)	to	achieve	uniform	labelling	(EM9	medium	can	be	adapted	for	e.g.	U-1H-15N,13C	or	U-1H-13C	labelling	–	see	Reagent	Setup)	or	Option	(B),	to	achieve	perdeuteration	and	selective	labelling	 of	 methyl	 sidechains.	 	 These	 two	 strategies	 can	 be	 used	 for	 implementing	alternative	labelling	schemes.		However,	given	the	relative	costs	associated	with	isotopic	labelling,	it	is	likely	that	uniform	labelling	approaches	(Option	(A))	would	be	considered	initially,	prior	to	more	complex	labelling	schemes	(e.g.	Option	(B)).		
OPTION	(A)	Uniform	U-15N-labelling	TIMING	2	d	
i. 	Inoculate	1	L	of	MDG	medium	with	cells	from	step	2	to	a	starting	OD600nm	of	0.05-0.1/mL.	Allow	the	cells	to	grow	and	reach	saturation	at	37°C,	180	rpm	(~16-20	h)	by	monitoring	OD600nm	measurements.	
ii. 	Pellet	 the	cells	at	2,200	x	g,	25	min,	4°C	and	gently	resuspend	 the	cells	 into	1	L	of	1	x	EM9	salts.	Repeat	once,	i.e.	pellet	the	cells	at	2,200	x	g,	25	min,	4°C	and	gently	resuspend	the	cells	into	1	L	of	1	x	EM9	salts	again.	
iii. Pellet	 the	 cells	 at	 2,200	 x	 g,	 25	 min,	 4°C	 and	 gently	 resuspend	 the	 cells	 in	 1	 L	 EM9	medium	containing	isotopes	as	desired	(e.g.	15N	NH4Cl	and/or	13C-glucose)	(see	Reagent	Setup)	and	induce	expression	of	the	polypeptide	by	adding	IPTG	to	the	medium	to	a	final	concentration	of	1	mM.	
iv. 	Incubate	the	cells	at	37°C,	180	rpm.	After	10	min,	add	rifampicin	to	a	final	concentration	of	150	µg/mL.	
v. 	Continue	 expression	 for	 35	 min	 at	 37°C,	 180	 rpm	 and	 then	 harvest	 the	 cells	 by	centrifugation	(2,500	x	g,	20	min,	4°C	).	Either	proceed	to	step	4,	or	store	the	cell	pellet	at	-20°C.	
PAUSE	POINT	This	sample	can	be	stored	at	-20°C	for	months.	
OPTION	(B)	Selective	labelling	of		13CH3	groups	TIMING	5-6	d	<CRITICAL>	The	growth	kinetics	of	E.	coli	using	deuterated	media	components	are	significantly	slower	(doubling	time	of	1-1.5	h	or	more),	hence	the	production	time	of	RNCs	using	this	strategy	requires	 longer	 than	 that	 for	 protonated	 (e.g.	 1H-15N)	 approaches.	 Here,	 the	 E.	 coli	 are	 first	grown	 in	 deuterium	 oxide	 using	 protonated	 carbon	 sources,	 followed	 by	 deuterated	 carbon	sources,	prior	to	large	scale	growth	and	expression;	this	generally	improves	the	reliability	in	E.	
coli	growth.		
i. 	Adapt	 the	 cells	 into	 perdeuterated	 media,	 first	 into	 deuterated	 media	 (containing	 D-glucose)	 and	 then	 subsequently	 into	 deuterated	 media	 with	 deuterated	 glucose,	 as	tabulated	below.	For	each	adaptive	step,	inoculate	5	mL	medium	to	a	starting	OD600nm	of	0.2-0.3/mL.	Allow	the	OD600nm	of	the	cells	to	reach	saturation	at	37°C	and	180	rpm,	which	
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can	range	between	20-24	h.	After	the	final	adaptive	stage,	centrifuge	the	culture	at	2,500	x	g,	20	min,	4°C.	
Adaptive	step	 Medium	 Glucose	source	1	 MDG	 D-Glucose	2	 Perdeuterated	MDG	 D-Glucose	3	 Perdeuterated	MDG	 D-	Glucose-1,2,3,4,5,6,6-d7		
ii. Use	 the	 cells	 pelleted	 from	 the	 final	 adaptive	 stage	 at	 step	 3B(i)	 to	 prepare	 a	 100	mL	culture	 in	 perdeuterated	MDG,	 grow	 to	 saturation	 and	 centrifuge	 as	 described	 in	 step	3B(i).	
iii. 	Use	 the	 cells	pelleted	 from	 the	 culture	 in	Step	3B(ii)	 to	 inoculate	500	mL	of	MDG	and	grow	the	cells	using	the	conditions	described	in	Step	3B(i).		
iv. 	Pellet	 the	 cells	 at	 3000	 x	 g	 for	 15	min	 and	 gently	 resuspend	 them	 in	 500	mL	 of	 EM9	medium	 together	 with	 the	 appropriate	 precursors	 (see	 Reagent	 Setup)	 required	 for	selective	methyl	labelling,	
v. Grow	 cells	 at	 37°C	 and	 180	 rpm	 and	monitor	 cell	 growth	 until	 the	 cells	 have	 reached	mid-log	phase	growth	(once	O.D.600	starts	to	increase).	
vi. 	Induce	expression	of	the	RNC	by	adding	IPTG	to	a	final	concentration	of	1	mM	and	grow	for	90	min	at	37°C.	Harvest	the	cells	by	centrifugation	(2,500	x	g,	20	min,	4°C),	and	either	proceed	to	step	4	or	store	the	cell	pellet	at	-20°C.	CRITICAL	STEP	Rifampicin	is	omitted	in	
the	production	of	[U-2H];	13CH3-labelled	RNCs	as	we	have	found	that	it	can	have	an	adverse	
effect	on	RNC	expression.		
PAUSE	POINT	This	sample	can	be	stored	at	-20°C	for	months.	
	
Purification	 of	 labelled	 RNCs	 by	 metal	 affinity	 chromatography	 and	 sucrose	 density	
gradient	centrifugation	TIMING	3	d	<CRITICAL	>	Use	gloves	for	steps	4-15	and	keep	all	reagents	and	samples	chilled	to	maintain	the	RNC	integrity.	4. Thaw	the	cells	at	room	temperature	(22°C)	and	resuspend	 in	Lysis	Buffer	(20	mL/L	of	cells).	 <CRITICAL	 STEP>	 Do	 not	 leave	 cells	 at	 room	 temperature	 for	 any	 longer	 than	required	for	thawing	to	take	place.	Alternatively,	the	cells	can	be	thawed	on	ice.	5. Lyse	the	cells	by	pressure	 in	a	French	Press,	4-6	passes	at	1000	psi.	Keep	the	cells	 ice-cold	between	passes.	6. Spin	 the	 cellular	 debris	 at	 40,000	 x	 g,	 4°C,	 45	 min.	 If	 the	 supernatant	 is	 not	 clarified	completely,	transfer	the	supernatant	to	a	new	tube	and	repeat	the	centrifugation.	
7. Load	 the	 clarified	 supernatant	 onto	 an	 ice-cold	 35%	 (w/v)	 sucrose	 cushion.	 Spin	 the	sucrose	 cushion	 at	 200,000	 x	 g,	 for	 4-12	 h,	 in	 an	 ultracentrifuge	 (Type	 45Ti	 rotor,	
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Beckman).	Optional:	Retain	the	resulting	supernatant	to	purify	the	released	nascent	chain	
if	desired	e.g.	to	compare	bound	versus	released	nascent	chains	by	NMR,	(e.g.	using	metal	
affinity	 chromatography	 with	 the	 user’s	 resin	 of	 choice,	 according	 to	 manufacturer’s	
instructions).	8. Gently	resuspend	the	ribosomal	pellet	in	Resuspension	Buffer	and	measure	the	ribosome	concentration	by	OD260nm	(1	OD260nm	=	24	pmol	/	mL).	<CRITICAL	STEP>	If	using	a	pipette	to	resuspend	the	pellet,	avoid	excess	bubble	formation	to	minimize	potential	release	of	the	nascent	chain.		9. Bind	 the	 ribosomal	 suspension	 to	 an	 appropriate	 metal	 affinity	 resin	 according	 to	manufacturer’s	instructions	for	1	h	at	4°C.	10. Wash	the	resin	with	Washing	Buffer,	according	to	manufacturer’s	instructions,	until	the	protein	detected	in	the	flowthrough	is	negligible	as	determined	visually	using	a	Bradford	assay.		11. Elute	 the	 RNC	 fraction	 with	 Elution	 Buffer,	 assessing	 when	 elution	 is	 complete	 as	described	in	Step	10	(typically	50-100	mL).	12. Concentrate	 the	 eluate	 in	 a	 100	 kDa	 cut-off	 concentrator	 according	 to	manufacturer’s	instructions,	to	a	70S	ribosome	concentration	of	up	to	10	nmol/mL	(see	Step	8),	at	3,000	x	 g	 and	 4°C.	 <CRITICAL	 STEP>	 For	 an	 accurate	measure	 of	 the	 OD260nm,	 the	 imidazole	should	be	removed	using	the	100	kDa	cut-off	concentrator	and	progressively	diluting	the	imidazole	concentration.		13. Using	 a	 gradient	 former,	 pour	 10-35%	 (w/v)	 sucrose	 gradients	 (35	ml,	 in	 25x89	mm	tubes)	 and	 load	 ≦1,500	 pmol	 of	 the	 RNC	 from	 step	 12.	 Spin	 the	 gradients	 in	 an	ultracentrifuge	at	64,000	x	g,	for	16-18	h.		14. Using	a	pump	and	fraction	collector,	fractionate	the	gradients	(1.0-1.5	mL)	and	monitor	elution	using	OD254nm	measurements.	Run	aliquots	(15	µL)	from	each	fraction	on	a	12%	(w/v)	polyacrylamide	gel	and	determine	the	presence	and	homogeneity	of	the	70S	RNC	peak	(as	shown	in	Figure	2b).	?TROUBLESHOOTING	
15. Buffer	 exchange	 the	 70S	 containing	 fractions	 using	 a	 100	 kDa	 cut-off	 concentrator	 to	dilute	 the	 sucrose	 content	 to	 the	 nanomolar	 concentration	 range	 using	 Tico	 buffer	 at	3,000	 x	 g	 and	 4°C.	 Measure	 the	 absorbance	 of	 the	 RNCs	 at	 OD260nm	 and	 OD280nm	 to	evaluate	 the	 70S	 content	 (see	 Step	 8)	 and	 its	 homogeneity	 using	 OD260/280nm	 ratio	(expected	range:	1.9-2.0)67.	The	resulting	RNC	sample	can	be	used	immediately	or	flash-frozen	using	liquid	N2	and	stored	at	-80°C.	
PAUSE	POINT	This	sample	can	be	stored	at	-80°C	for	months.	
Biochemical	analysis	of	the	purified	RNC	samples	TIMING	2	d	
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16. Prepare	or	purchase	neutral	pH	gels	with	a	polyacrylamide	concentration	 that	permits	resolution	 of	 the	 nascent	 chain	 of	 interest	 and	 prepare	 the	 low	 pH	 loading	 dye.	<CAUTION>	Wear	gloves	when	handling	polyacrylamide,	which	is	a	neurotoxin.	
17. To	assess	the	RNC	integrity	and	nascent	chain	occupancy,	 load	the	polyacrylamide	gels	with:	2-10	pmol	samples	of:	untreated	RNC	(from	step	15);	RNC	(from	step	15)	treated	with	10	µg	RNase	A	to	digest	the	ribosomal	RNA	(at	room	temperature	for	5	min),	along	with	a	series	of	concentration	standards	of	the	isolated	protein	of	interest.	18. Using	 standard	 western	 blot	 procedures,	 transfer	 the	 gels	 onto	 a	 nitrocellulose	membrane	and	probe	with	an	antibody	that	recognises	the	RNC	(e.g.	anti-His,	anti-SecM)	and	detect	using	chemilluminescence	68	<CRITICAL	STEP>	Minimise	direct	contact	with	nitrocellulose	membrane	to	avoid	cross-contamination.		19. Using	ImageJ	software,	quantify	the	nascent	chain	occupancy	by	densitometry	analysis:	Measure	the	intensity	of	the	chemilluminescent	signal	arising	from	the	isolated	protein	standards	and	generate	a	standard	curve.	Determine	the	concentration	of	nascent	chain	present	in	the	RNase	A-treated	RNCs	using	the	standard	curve	of	the	isolated	protein	and	the	concentration	of	the	RNCs	(based	upon	the	70S	concentration	at	OD260nm).	Note	that	a	similar	 procedure	 can	 be	 applied	 for	 detecting	 the	 presence	 of	 trigger	 factor	 and	 any	other	ribosome/nascent	chain	associated	proteins.	?TROUBLESHOOTING	
NMR	data	acquisition	and	parallel	biochemical	experiments	TIMING	1-2	d	
20. After	thawing	the	RNC	sample	(from	step	15)	on	ice	use	a	100	kDa	concentrator	and	Tico	buffer	 to	remove	any	released	nascent	chain	using	a	buffer	exchange.	Measure	 the	70S	ribosome	concentration	at	OD260nm.	For	selectively	protonated	samples,	buffer	exchange	in	Tico	Buffer	in	D2O	with	deuterated	HEPES.	
21. Transfer	approximately	10%	of	the	RNC	sample	to	a	separate	tube	and	incubate	at	the	same	temperature	as	used	for	NMR	acquisition	for	the	duration	of	NMR	acquisition.	Collect	aliquots	at	regular	intervals		(e.g.	hourly)	for	subsequent	western	blot	analysis	of	RNC	integrity	over	time	(see	Box	2).			22. Supplement	 the	 remainder	 of	 the	 RNC	 sample	 from	 step	 21	with	 10%	 (v/v)	 D2O	 and	0.001%	(w/v)	DSS	and	 load	300	µL	 into	a	Shigemi	 tube	and	begin	NMR	acquisition	as	detailed	in	steps	23	and	24.		23. 	For	uniformly	15N	and/or	13C-labelled	samples	only:	Acquire	experiments	as	tabulated	below.	Use	the	spectra	produced	in	the	15N	edited	and	15N	filtered	experiments	to	identify	the	resonances	arising	from	the	ribosome	in	the	amide	region	(7-9	p.p.m.,	15N-labelled	samples)	or	the	methyl	region	(0.7-1	p.p.m.	,13C-labelled	samples).	The	percentage	of	background	labelling	from	the	relative	amount	of	bL12	resonance	intensities	can	be	calculated	as	observed	in	either	spectra.		
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Type	of	experiment	 Purpose	 Analysis	step(s)	
15N-edited	1H-15N	SOFAST	HMQC	 Record	the	first	increment		 The	 species	 observed	 in	 this	experiment	 are	 15N-bound	protons.	15N-filtered	 1H-15N	 SOFAST	HMQC	 Record	the	first	increment		 The	species	observed	in	this	experiment	are	14N-bound	protons.	15C-edited	1H-13C	SOFAST	HMQC	 Record	the	first	increment		 The	species	observed	in	this	experiment	are	13C-bound	protons.	13C-filtered	1H-13C	SOFAST	HMQC	 Record	the	first	increment		 The	species	observed	in	this	experiment	are	12C-bound	protons.		24. 	Acquire	 the	 NMR	 experiments	 detailed	 in	 the	 table	 below	 in	 an	 interleaved	 manner	(refer	 to	 Box	 1	 for	 further	 details	 concerning	 the	 NMR	 experimental	 design):	?TROUBLESHOOTING		
Type	of	experiment	 Purpose	
1H	1D	experiment	 Monitor	 the	 amide	 region	 (7-9	 p.p.m.),	 ribosomal	resonances	 in	 the	 methyl	 region	 (0.7-1	 p.p.m.),	 buffer	resonances.	2D	15N-1H	or	13C-1H	correlation	experiment	 Obtain	 spectra	 reporting	 on	 nascent	 chain	 conformations	and	dynamics.		Heteronuclear	 diffusion:	 E.g.	 15N	 XSTE	diffusion38,	 SORDID	 diffusion60,	 69	 or	 13C-edited	STE	diffusion39	experiment	
Monitor	 the	 diffusion	 coefficient	 associated	 with	 the	resonances	 observed	 in	 2D	 experiments	 and	 from	 this	assess	the	nascent	chain	attachment	to	the	ribosome.		1H	STE	diffusion	experiment	 Monitor	 the	 diffusion	 coefficient	 associated	 with	 the	methyl	resonances	in	1D	experiments	and	from	this	assess	the	integrity	of	the	ribosome.			 	
	Analysis	of	RNC	sample	integrity	over	time	TIMING	2	d	25. Analysis	 of	 1H	 1D	 spectra	 to	 evaluate	 ribosomal	 resonances.	 Process	 each	 1H	 1D	spectrum	 and	 analyse	 resonances	 (methyl	 resonances,	 0.7-1.0	 p.p.m.)	 specifically	 arising	from	the	ribosomal	background	(mainly	from	protein	bL12)	and	buffer	components	such	as	
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HEPES	(2.6-3.8	p.p.m.).	Note	the	timeframe	during	which	the	signals	remain	unchanged.	We	typically	 process	 the	 spectra	 in	NMRPipe64	 and	 convert	 the	 data	 to	 a	 text-file	 format,	 then	generate	a	stacked	overlay	using	MATLAB	software.	26. Analysis	 of	 the	 1H	 STE	 diffusion	 spectra	 to	 evaluate	 the	 translational	 diffusion		Process	each	1H	STE	diffusion	spectrum.	Integrate	the	resonances	arising	from	the	ribosomal	background	(methyl	region)	for	each	of	the	gradient	strengths,	and	plot	the	integrated	signal	against	 the	 time	 of	 acquisition.	 Determine	 the	 noise	 level	 of	 the	 signal	 integral.	 This	 is	 the	standard	deviation	calculated	from	integrated	signals	that	have	been	randomly	selected	from	30-35	regions	of	identical	bandwidth	within	the	baseline	of	the	spectra.	27. Determine	 translational	 diffusion	 coefficients	 of	 the	 observed	 ribosomal	 resonances	using	the	Stejskal-Tanner	equation70	(Equation	1)	which	relates	the	attenuation	in	signal	at	a	given	strength	of	the	pulsed-field	gradient	to	the	diffusion	coefficient,	D.	𝐼𝐼" = exp	[−𝐷𝛾,𝜎,𝛿,𝐺, ∆ − 𝛿3 − 𝜏2 ]			(Equation	1)	where	I	and	I0	are	the	intensities	at	the	two	gradient	strengths,	γ	is	the	1H	gyromagnetic	ratio	(2.67522128x108	 rad	 s-1	 T-1),	 σ	 is	 the	 shape	 factor	 (0.9	 for	 a	 square	 gradient),	 Δ	 is	 the	diffusion	delay	(100	ms),	δ	is	the	length	of	the	gradient	pair	(4	ms),	G	is	the	gradient	strength,	τ	 is	 the	 delay	 between	 gradient	 pulses	 in	 bipolar	 gradient	 pairs,	 and	 D,	 the	 diffusion	coefficient.	 	Use	either	 the	ratio	 in	 intensities	of	5%	and	95%	or	50%	and	95%	 of	 the	 total	gradient	strength,	G	in	order	to	determine	a	value	for	the	diffusion	coefficient	D.		28. Determining	the	period	of	ribosome	stability.	Using	the	1H	1D	plots	produced	in	step	25,	evaluate	over	time	the	methyl	resonances	arising	from	the	ribosomal	background	protein,	together	 with	 the	 plots	 of	 translational	 diffusion	 produced	 in	 step	 27.	 Determine	 the	timeframe	 during	 which	 these	 observations	 remain	 unchanged	 and	 which	 reports	 on	 an	intact	70S	complex.	29. Analysis	 of	 the	 13C-edited	 STE	 or	 15N	 XSTE	 (SORDID)	 spectra	 to	 determine	 the	
period	 of	 nascent	 chain	 attachment.	 Process	 each	 13C-edited	 STE	 /	 15N	 XSTE	 /	 SORDID	diffusion	spectrum	using	NMRPipe	software:	Repeat	analyses	as	described	in	step	27,	using	gradient	strengths	5%	G	and	95%	G.	For	15N	XSTE	diffusion	(or:	SORDID	diffusion),	integrate	signals	arising	from	the	amide	region	(7.9-8.4	p.p.m.)	in	the	1H	dimension.	For	13C-edited	STE	diffusion,	 diffusion	 analysis	 can	 be	 performed	 on	 resonances	 arising	 from	 the	 ribosome	(methyl	region:	0.8-1	p.p.m.	on	the	1H	axis)	as	well	as	any	discrete,	well-dispersed	resonances	arising	from	the	nascent	chain	that	are	present	in	these	spectra.		
30. Determine	 the	 noise	 level	 of	 the	 integrated	 signal	 as	 the	 standard	 deviation	 of	 the	integral	of	signal	in	2-3	regions	of	identical	bandwidth,	chosen	randomly	in	baseline	parts	of	the	 spectrum	 between	 6.5	 p.p.m.	 and	 11.5	 p.p.m.	 in	 the	 1H	 dimension	 for	 15N	 XSTE	 (or	SORDID)	diffusion,	 and	between	 -2	p.p.m.	and	1.5	p.p.m.	 in	 the	 1H	dimension	 for	 13C-edited	
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STE	diffusion.	Average	a	number	of	13C-edited	STE	or	15N	XSTE	spectra	if	the	uncertainties	in	diffusion	measurements	are	too	large.	If	this	is	not	possible,	refer	to	step	31.	31. Analysis	of	heteronuclear	correlation	spectra	to	monitor	sample	stability.	Process	each	 1H-13C	 methyl-TROSY	 HMQC	 or	 1H-15N/13C	 SOFAST-HMQC	 spectrum	 using	 NMRPipe	software,	following	manufacturer’s	instructions.	Select	discrete,	unambiguous	resonances	for	subsequent	analysis.	If	the	isolated	protein	has	been	assigned,	identify	the	RNC	resonances	by	spectral	 overlay	 and	 transfer	 assignments.	 Determine	 peak	 heights	 for	 the	 resonances	 of	interest,	as	well	as	peak	heights	for	any	discrete	ribosomal	bL12	resonances.	32. Determine	 peak	 heights	 of	 (typically	 100)	 randomly	 chosen	 positions	 in	 the	 same	chemical	 shift	 range	 as	 the	 RNC	 resonances	 within	 a	 spectrum.	 The	 uncertainty	 of	 each	intensity	measurement	 in	 step	 31	 is	 given	 by	 the	 standard	 deviation	 of	 the	 noise	 intensity	measurements.	33. Plot	 averaged	 peak	 heights	 of	 the	 resonances	 arising	 from	 the	 nascent	 chain	 and	ribosomal	 protein	 bL12	 over	 time.	 Intensity	 changes	 are	 typically	 indicative	 of	 sample	breakdown.	
Characterisation	of	the	structural	and	dynamical	properties	of	the	RNC.TIMING	0.5	d	34. Once	the	timeframe	during	which	the	RNC	remains	intact	has	been	established	using	the	approaches	 in	 steps	 24-33,	 sum	 the	 corresponding	 heteronuclear	 correlation	 spectra.	 A	residue-by-residue	 analysis	 of	 the	 heteronuclear	 spectra	 can	 be	 undertaken,	 using	 2D	correlation	 spectra	 by	 comparing	 spectra	 of	 the	 isolated	 protein	 in	 the	 presence	 of	 70S	ribosomes,	as	described	in	Experimental	design.	
	
	
TROUBLESHOOTING	Troubleshooting	advice	is	provided	in	Table	1.		Table	1.	Troubleshooting	
STEP	 PROBLEM	 POSSIBLE	REASON	 POSSIBLE	SOLUTION	step	14	 Poor	separation	of	70S	from	contaminants	during	sucrose	gradient	centrifugation.	
-Gradients	were	overloaded	with	sample.				-Gradients	not	uniform	or	pre-chilled.	
-	Load	less	material	and/or	increase	the	number	of		gradients.		-	Prepare	gradients	using	a	gradient	former	and	chill	all	tubes	until	required.		step	24	 Few	or	no	RNC	resonances	can	be	observed.	
-The	sample	concentration	is	too	low,	has	been	compromised			-Sample	not	efficiently	
-Ensure	that	the	sample	is	intact	(Box	2)	and	at	a	concentration	in	the	µM	range.		Check	whether	there	is	signal	for	bL12	in	the	methyl	region	of	the	spectrum	if	applicable.		-	Evaluate	the	timing	of	isotope	addition	to	the	media	
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isotopically-labelled		-NMR	acquisition	parameters	do	not	allow	observation	of	the	nascent	chain		-	Structural	and/or	dynamic	characteristics	of	the	RNC	(e.g.	conformational	exchange,	interaction	with	the	ribosome		
		-Evaluate	and	optimise	NMR	acquisition	parameters	as	required		(e.g.	acquisition	time,	sweep	widths,	temperature).				-Evaluate	the	NMR	characteristics	of	the	isolated	polypeptide	and	the	extent	of		interaction	with	70S	ribosomes.		-Re-design	RNC	system	as	needed			step	24	 Large	extent	of	70S	background	labelling.	 Expression	step	may	have	allowed	time	for	the	production	of	labelled	70S	particles	during	exposure	to	labelled	isotopes.	
-Optimise	expression	time	for	RNC	production	-Evaluate	the	use	of	rifampicin	during	expression.	
Box	2	 No	or	little	expression.	 Expression	conditions	need	optimising	for	specific	nascent	chain.	
-	Evaluate	expression	conditions	on	a	small	scale,	by	varying	parameters	such	as	E.	coli	cell	line/vector,	expression	time	and	temperature.	Detect	RNC	expression	via	western	blotting.		Box	2	 Low	yield.	 Poor	expression	(steps	2-3),	poor	recovery	during	preparative	steps.		
-	Collect	aliquots	throughout	expression	and	purification	procedures	and	use	western	blotting	to	troubleshoot.	-	Re-design	RNC	to	include	alternative	purification	tags	(e.g.	solubility	tags)	Box	2	 Multiple	bands	detected	on	western	blot	/	Bands	on	silver	stained	SDS	PAGE	do	not	look	like	70S	ribosome.	
-Poor	expression	of	the	RNC	(Steps	2-3).			-Integrity	of	the	RNC	sample	has	been	compromised	by	dissociation/degradation	or	proteolysis.	
-	Evaluate	RNC	expression.		-	Ensure	all	buffer	compositions	are	correct.			-	Use	online	web	tools	to	evaluate	possible	protease	cleavage	sites	in	the	nascent	chain	sequence	(using	e.g.	PeptideCutter 
web.expasy.org/peptide_cutter/).		Supplement	buffers	with	specific	protease	inhibitors	as	necessary.	
	
	
TIMING	Steps	1-	3:	Generation	of	isotopically-labelled	RNCs	2	weeks	–	1	month	Steps	4-15:	Purification	of	labelled	RNCs	by	metal	affinity	chromatography	and	sucrose	density	gradient	centrifugation	3	d	Steps	16-19:	Biochemical	analysis	of	the	purified	RNC	samples	2	d	Steps	20-24:	NMR	data	acquisition	and	parallel	biochemical	experiments	1-2	d	Steps	25-33:	Analysis	of	RNC	sample	integrity	over	time	2	d	Step	34:	Characterisation	of	the	structural	and	dynamical	properties	of	the	RNC	0.5	d	
	
	
ANTICIPATED	RESULTS	
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Following	 expression	 (steps	 2-3),	 the	 cells	 are	 lysed	 (steps	 4-5)	 and	 the	 soluble	 cell	lysate	is	subjected	to	a	35%	(w/v)	sucrose	cushion	from	which	~50-100	nmol	of	ribosomes	can	be	 recovered	 per	 litre	 of	 E.	 coli	 culture	 (steps	 6-8).	 The	 ribosomal	 suspension	 (a	 mixture	 of	RNCs,	 empty	 70S	 ribosomes,	 ribosomal	 subunits	 and	 released	 nascent	 chains)	 is	 applied	 to	 a	metal	affinity	column,	which	recovers	the	fraction	containing	RNCs,	resulting	in	6000-9000	pmol	of	material	 (steps	9-12).	Further	purification	using	a	10-35%	(w/v)	high-salt	 sucrose	gradient	permits	 the	separation	of	other	contaminating	species,	 including	ribosome-associated	proteins	(steps	13-14	and	Fig.	2a,	b).	Following	purification,	3-6	nmol	(7-15	mg)	of	RNCs	can	typically	be	purified	 to	 homogeneity	 per	 litre	 of	 culture,	 representing	 6-18%	 of	 the	 total	 ribosomal	population	recovered	 from	 the	cell	 lysate	 (step	15).	This	value	 is	 representative	of	 the	overall	purification	 yield	 rather	 than	 the	 extent	 of	 SecM	 translational	 arrest	 occurring	 in	 vivo,	 which	may	be	significantly	greater.	Following	these	preparative	steps,	the	degree	of	translational	arrest	in	 the	purified	sample,	estimated	using	 isolated	protein	standards	of	known	concentrations,	 is	typically	observed	to	be	>90%	(steps	16-19	and	Fig.	2c,	d).	Within	the	RNC	sample,	the	extent	of	70S	background	isotopic	labelling	is	subsequently	evaluated	using	a	combination	of	15N	(or	13C)	filtered	1D	proton	and	edited	1D	proton	spectra,	in	which	for	the	case	of	uniformly	15N-labelled	samples,	 the	 intensity	 of	 the	 envelope	 of	 14N-bound	 protons	 arising	 from	 the	 ribosomal	 bL12	resonances	 (unlabelled	 amides)	 are	 compared	 against	 that	 of	 15N-bound	 protons	 (labelled	amides);	 an	 analogous	 approach	 is	 used	 for	 uniformly	 13C-labelled	 samples	 (step	 23).	 We	observe	that	typically	5-15%	of	the	bL12	protein	 is	 isotopically-labelled,	and	therefore	overall,	ribosome	background	 labelling	of	 this	magnitude	 contributes	only	minimally	 to	heteronuclear	experiments	 (Supplementary	 Fig.	 2).	 	 Variability	 in	 overall	 RNC	 yields	 relates	 to	 the	 nascent	chain	system,	and	is	thus	considered	on	a	case-by-case	basis	(see	Troubleshooting	for	details).	To	 illustrate	 how	 we	 can	 use	 NMR	 to	 observe	 successive	 stages	 of	 the	 folding	 of	 an	emerging	nascent	chain,	here	we	show	two	RNC	examples	from	our	studies1	of	the	biosynthesis	of	an	immunoglobulin	domain	derived	from	the	multi-domain	protein,	FLN.	These	RNCs	mimic	the	progressive	emergence	and	co-translational	folding	of	FLN5,	and	consist	of	FLN5	tethered	to	increasing	numbers	of	residues	of	the	subsequent	domain,	FLN610,	and	a	SecM	stalling	sequence.	In	the	FLN5+21	RNC	construct,	the	FLN5	domain	resides	21	residues	from	the	PTC,	which	is	in	the	vicinity	of	the	ribosomal	exit	tunnel.	In	FLN5+110	RNC,	the	nascent	chain	is	separated	by	a	significant	distance	(110	residues)	from	the	PTC1,	10	(Fig.	4a,	b).	Resonances	in	1H-15N	correlation	spectra	 of	 FLN5+21	 RNC	 give	 rise	 to	 a	 narrow	 resonance	 dispersion	 in	 the	 1H	 dimension	consistent	with	a	disordered	conformation,	while	1H-13C	HMQC	spectra	of	[U-2H];	Ileδ1-[13CH3]-labelled	 FLN5+110	RNC	 show	dispersed	 resonances	 characteristic	 of	 a	well-folded	 protein,	 as	well	as	intense	overlapped	resonances	characteristic	of	disordered	conformations.		To	 ensure	 that	 these	 resonances	 arise	 from	 a	 ribosome-attached	 nascent	 chain,	examination	of	both	western	blot	and	diffusion	analyses	is	recommended	(steps	29-30	and	Box	
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2).	In	the	case	of	the	disordered	FLN5+21	RNC	sample,	western	blot	analyses	reveal	a	significant	change	in	the	intensity	of	the	tRNA-bound	nascent	chain	band	after	t=2.1	h	(Fig.	4c)	as	observed	in	 the	 anti-His	 blot	 (top),	 and	 after	 t=5.9	 h	 in	 an	 anti-SecM	blot	 (bottom).	 Similarly,	 15N	XSTE	diffusion	data	reveal	changes	in	D	beyond	t=2.1	h,	suggesting	that	within	this	2	h	timeframe,	the	RNC	 is	 intact	 (Fig.	 4e).	 For	 the	FLN5+110	RNC,	both	 the	anti-His	 and	anti-SecM	western	blots	(Fig.	 4d)	 indicate	 that	 the	 tRNA-bound	 nascent	 chain	 remains	 stable	 throughout	 an	 NMR	acquisition	 period	 of	 17	 h,	 beyond	which,	 NMR	 data	 are	 not	 included	 in	 the	 analysis.	 Indeed,	lower	molecular	weight	 bands	 observable	 in	 the	 anti-SecM	blot	 at	 t=32	 h	 are	 consistent	with	truncation	of	the	nascent	chain.	In	addition,	the	diffusion	coefficient,	D,	can	also	be	determined	from	 13C-edited	 STE	 experiments	 on	 discrete	 resonances	 arising	 exclusively	 from	 the	 nascent	chain,	 and	 reports	 an	 intact	 RNC	 (D=1.5	 ±	 0.3	 x10-11	 m2s-1)	 until	 t=17	 h	 (Fig.	 4f).	 Generally,	changes	in	the	intensity	of	the	tRNA-bound	nascent	chain	band	in	excess	of	10%	of	the	original	intensity	are	regarded	as	significant,	as	 these	could	give	rise	to	 interfering	NMR	signals.	These	intensity	 changes	 are	 also	 often	 concomitant	 with	 the	 appearance	 of	 lower	molecular	 weight	bands	 that	 we	 attribute	 to	 nascent	 chain	 release	 (e.g.	 overcoming	 translational	 arrest	 or	proteolysis),	 and	 an	 increase	 in	 the	 diffusion	 coefficient	 associated	 with	 the	 nascent	 chain	resonances.	The	timeframe	during	which	the	nascent	chain	 is	stable	within	a	given	RNC	varies	between	 sample	 preparations	 and	 the	 integrity	 of	 each	 sample	 during	 the	 course	 of	 its	 NMR	acquisition	is	therefore	considered	on	an	individual	basis.	Structural	 NMR	 spectra	 (such	 as	 heteronuclear	 correlation	 spectra,	 RDC	 or	 dynamics	data)	reflecting	intact	RNCs	are	typically	summed	and	analysis	of	the	structural	and	dynamical	properties	of	 the	RNC	undertaken.	 In	this	example	the	shortest	nascent	chain	 length,	FLN5+21	RNC,	 shows	 disordered	 resonances	 in	 1H-15N	 correlation	 spectra	 which	 overlay	 closely	 with	those	of	a	corresponding	disordered	isolated	variant,	(termed	FLN5∆12,	Fig.	4a).	This	suggests	similar	 conformations	 of	 the	 two	 samples	 and	 a	 disordered	 FLN5	 nascent	 chain	 when	 the	domain	 is	 close	 to	 the	 ribosomal	 exit.	 In	 contrast,	 once	 the	 linker	 length	has	 increased	 to	110	residues,	the	resonances	observed	for	[U-2H];	Ileδ1-[13CH3]-labelled	FLN5+110	RNC	were	found	to	overlay	closely	with	those	of	isolated	natively-folded	FLN5.	Four	dispersed	methyl	resonances	(corresponding	 to	 I738,	 I743,	 I674,	 and	 I695,	within	 0.01	 p.p.m.	 in	 the	 1H	 dimension)	 can	 be	identified,	and	where	 I748	 is	discernible	but	overlaps	 in	most	spectra	with	resonances	arising	from	the	ribosomal	stalk,	resulting	from	background	labelling	(Fig.	4b).	These	data	demonstrate	that	FLN5+110	RNC	adopts	a	native	FLN5	fold.		These	experiments	have	provided	the	foundation	for	examining	“structural	snapshots”	of	a	nascent	chain	during	synthesis	and	folding	on	the	ribosome.	This	will	allow	the	determinants	of	co-translational	protein	folding	and	the	influence	of	scenarios	unique	to	the	emerging	nascent	chain	 including	 the	 vectorial	 emergence	 of	 the	 amino	 acid	 sequence,	 the	 presence	 of	 the	
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ribosome,	and	the	role	of	molecular	chaperones	to	be	explored	at	a	residue-specific	level	and	at	high	resolution.		
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Box	1	Sensitivity	versus	resolution	The	upper	limit	of	70S	ribosome	particle	working	concentration	is	~10	µM	which	corresponds	to	a	very	high	24	mg/mL	of	70S	 in	 solution.	This	 concentration	 represents	a	major	 sensitivity	challenge	for	modern	biological	NMR	investigation	in	particular	when	combined	with	the	limited	stability	 of	 RNCs	 in	 solution.	 	 In	 RNC	 NMR	 studies	 it	 is	 crucial	 to	 optimise	 proposed	 NMR	experiments	 in	 order	 to	maximise	 signal71.	 The	 sensitivity	 of	 2D	NMR	experiments	 for	 a	 fixed	total	acquisition	time	and	spectral	resolution	is	determined	by	several	factors	(see	inset	figure):	[NC]	 is	 the	nascent	chain	concentration,	T	 is	 the	 total	acquisition	time,	B0	 is	 the	magnetic	 field	strength,	T2	is	the	transverse	relaxation	rate	in	the	indirect	dimension,	and	t1,max	is	the	maximum	evolution	time	in	the	indirect	dimension,	which	is	proportional	to	the	frequency	resolution.	The	nascent	chain	concentration	[NC],	is	the	limiting	factor	in	determining	the	overall	sensitivity.	By	contrast,	there	are	diminishing	returns	for	increases	in	the	total	acquisition	time	T,	as	a	result	of	the	T1/2	dependence.	The	frequency	resolution	in	the	indirect	dimension	(as	determined	by	the	maximum	 evolution	 time	 t1,max)	 is	 another	 key	 choice,	 as	 there	 is	 an	 inevitable	 compromise	between	sensitivity	and	resolution.	We	optimise	t1,max	using	the	analogous	isolated	protein	of	the	RNC	system	and,	 in	the	first	 instance,	acquire	2D	heteronuclear	spectra	for	an	uncharacterised	RNC	using	 the	 lowest	acceptable	resolution	 (e.g.	 t1,max = 14.1 ms) to	maximise	 the	overall	NMR	signal.	Acquisition	 at	 higher	 field	 strengths	 is	 also	 likely	 to	 be	beneficial	 as,	 in	 addition	 to	 the	direct	sensitivity	gains	due	to	the	increased	field	strength,	spectra	can	be	acquired	with	identical	chemical	shift	resolution	(in	p.p.m.)	but	with	shorter	evolution	times,	(t1,max	and	t2,max),	 thereby	reducing	 relaxation	 losses.	 However,	 for	 some	 systems,	 it	 is	 possible	 that	 chemical	 exchange-induced	line	broadening	may	reduce	sensitivity	of	some	resonances	at	higher	fields.	This	should	be	 assessed	 on	 a	 case-by-case	 basis,	 ideally	 using	 an	 isolated	 RNC	 analogue,	 in	 order	 to	determine	 the	 combination	 of	 field	 strength	 and	 evolution	 times	 that	 optimise	 sensitivity	 or	resolution	as	required.	In	our	own	hands,	we	have	only	observed	positive	effects	on	increasing	the	field	strength	from	700	to	950	MHz,	and	as	1.2	GHz	fields	are	likely	to	become	available	in	the	 next	 few	 years,	 the	 prospect	 of	 further	 improvements	 in	 sensitivity	 is	 encouraging.	 In	addition,	 by	 implementing	 in	 advance	 an	 appropriate	 apodization	 function,	 the	 use	 of	 non-uniform	weighted	 sampling	 methods	 can	 provide	 additional	 sensitivity	 improvements	 of	 10–20%,	without	distortion	of	the	resulting	spectra72.	Further	recent	developments	include	the	use	of	 soluble	 paramagnetic	 compounds	 that	 can	 be	 introduced	 into	 NMR	 samples,	 strongly	accelerating	 longitudinal	 relaxation	 and	 hence	 increasing	 sensitivity	 at	 a	 cost	 of	 only	 little	relative	effect	on	transverse	relaxation.	This	paramagnetic	longitudinal	relaxation	enhancement	(PLRE)	effect	has	been	shown	to	yield	sensitivity	gains	of	up	to	85%	on	RNC	samples	when	using	the	Ni(II)	chelate	NiDO2A60.	
Box	1	inset	figure.	END	OF	BOX	1 	
Box	2	Analysis	of	RNC	sample	integrity	during	NMR	acquisition	TIMING	1.5	d	1. Run	the	samples	collected	during	NMR	acquisition	on	a	12-15%	polyacrylamide	SDS	PAGE	gel.	Include	the	following	control	samples:	purified	70S	ribosome	to	check	for	nonspecific	antibody	binding,	and	a	sample	of	RNase	A-treated	RNC	as	a	control	for	released	nascent	chain.	2. Perform	a	western	blot	using	an	anti-His,	anti-SecM	and/or	other	nascent	chain-specific	antibody.	
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3. Monitor	for	the	presence	of	a	band	corresponding	to	the	molecular	weight	of	the	tRNA-bound	nascent	chain,	as	well	as	for	the	appearance	of	released	nascent	chains.	4. Use	densitometry	software	to	measure	the	tRNA-bound	nascent	chain	for	each	sample,	and	plot	the	raw	value	relative	to	time	
END	OF	BOX	2			
Figures	
Figure	1.	General	scheme	for	structural	studies	of	RNCs	by	NMR	spectroscopy.	An	outline	of	RNC	design,	preparation,	and	subsequent	analysis	by	NMR	spectroscopy	and	biochemistry,	as	described	in	the	Overview	of	the	Procedure	section.	
	
Figure	2.	Biochemical	assessment	of	purified	RNCs	
a	Following	Ni2+	metal	affinity	purification,	 the	RNCs	are	subjected	to	a	10-35%	(w/v)	sucrose	gradient.	 The	 fractionation	 profile	 is	 monitored	 by	 OD254nm.	 b	 The	 resulting	 fractions	 are	examined	 by	 SDS	 PAGE	 for	 the	 pattern	 corresponding	 to	 intact	 70S	 ribosomal	 proteins	 and	boxed	in	red	are	the	pooled	fractions.	The	typical	banding	pattern	consistent	with	70S	ribosomal	proteins	includes	S1	(60	kDa),	and	a	collection	of	ribosomal	proteins	<30	kDa.			c	An	anti-His	western	blot	of	a	FLN5	RNC	(FLN5+67	RNC)	following	purification,	showing	tRNA-bound	 and	 released	 nascent	 chain,	 which	 differ	 in	 molecular	 weight	 by	 ~17-20	 kDa.	 d	 For	nascent	 chain	 occupancy	 estimation,	 1-2	 pmol	 of	 RNC	 (ribosomal	 concentration)	 and	 varying	concentrations	of	isolated	FLN5	(0.25-2.5	pmol)	are	blotted	on	the	same	membrane.	A	standard	curve	 (inset)	 uses	 the	 band	 intensities	 derived	 from	 densitometry	 analyses	 of	 isolated	 FLN5	concentration	standards.		
Figure	3.	NMR	analysis	of	RNC	integrity		
a	15N	diffusion	measurements:	top	The	RNC	amide	envelope	is	shown	at	two	gradient	strengths	(5	 and	 95%	 G),	 at	 three	 different	 timepoints	 during	 NMR	 acquisition.	middle	 The	 integrated	amide	 envelope	 signal	 is	 shown	 throughout	 NMR	 acquisition,	 highlighting	 the	 timepoints	 for	which	 the	 spectra	 are	 shown	 on	 top.	 bottom	 The	 calculated	 diffusion	 coefficient	 D	 is	 shown	throughout	NMR	acquisition,	again	highlighting	the	timepoints	for	which	the	spectra	are	shown	on	top.	b	The	methyl	region	(0.7-1	p.p.m.)	in	1H	1Ds	contains	predominantly	resonances	arising	from	 the	 ribosomal	 protein	 bL12,	which	 can	 be	monitored	 as	 a	 probe	 for	 the	 integrity	 of	 the	ribosome.	The	methyl	 region	 of	 the	 1H	1D	 spectrum	 is	 assessed	 over	 the	 time	 course	 of	NMR	acquisition.	c	Integrated	signal	between	0.79	and	0.97	p.p.m.	of	1H-STE	diffusion	spectra	of	FLN5	RNC	recorded	at	 three	gradient	strengths.	0%	G	 represents	the	signal	observed	 in	1H	1Ds.	The	diffusion	 coefficient	 of	 the	 RNC	 can	 be	 determined	 from	 the	 ratio	 of	 the	 integrated	 signals	between	50%	G	 and	95%	G,	 plotted	over	 time.	The	diffusion	coefficient	expected	 for	an	 intact	
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ribosomal	particle	 is	 indicated	by	the	shaded	area	(D	=	1.7-2.2	10-11	m2s−1).	d	Plot	of	the	mean	intensities	 observed	 in	 1H-15N	 HMQCs	 of	 Dom5+47	 RNC	 over	 time,	 corresponding	 to	 natively	folded	FLN5.	e	Comparison	of	the	1H-15N	SOFAST	HMQC	at	the	start	of	acquisition	(t	=	0-8	h)	and	at	 the	 end	 of	 acquisition	 (t	 =	 87-95	 h),	 highlighting	 the	 appearance	 of	 folded	 FLN5	 (circled),	which	we	attribute	to	degradation	of	the	sample	through	release.	Disordered	FLN5	can	also	be	detected	in	the	central	region	of	the	spectrum	at	t	=	87-95	h,	which	we	attribute	to	proteolysis.				
Figure	4.	Heteronuclear	spectra	of	RNCs	and	monitoring	of	RNC	integrity	The	 orthogonal	 approaches	 used	 to	 evaluate	 RNC	 integrity	 are	 shown	 for	 a	 U-15N-labelled	FLN5+21	 RNC	 and	 b	 [U-2H];	 Ileδ1-[13CH3]-labelled	 FLN5+110	 RNC.	 Schematic	 of	 the	 DNA	construct	design	and	RNC	complexes	are	shown,	as	well	as	heteronuclear	correlation	spectra	of	the	 RNCs:	 a	 1H-15N	 SOFAST-HMQC	 spectrum	 of	 FLN5+21	 RNC	 (black),	 a	 1H-15N	 correlation	spectrum	 of	 a	 C-terminally	 truncated	 FLN5	 sample	 (FLN5∆12)	 (red),	 and	 an	 overlay	 of	 both,	which	 enables	 assignment	 of	 the	 RNC	 resonances	 by	 attribution	 as	 indicated.	b	 1H-13C	 HMQC	spectrum	of	folded	FLN5+110	RNC	(black),	a	1H-13C	HMQC	of	isolated	FLN5	(red)	and	an	overlay	of	both,	which	enables	assignment	of	 the	RNC	resonances	by	attribution.	The	cross-peaks	 that	overlay	with	 isoleucine	resonances	arising	from	folded	FLN5,	as	well	as	those	arising	from	the	background	labelled	ribosome,	are	indicated.	c	and	d	Western	blot	analyses	of	the	samples	of	the	RNCs	over	the	time	course	of	NMR	acquisition:	anti-His	(top),	and	anti-SecM	(bottom).	e	15N	X-STE	 spectra	 of	 FLN5+21	 RNC	 recorded	 at	 two	 gradient	 strengths	 (5	 and	 95%	G).	 Changes	 in	diffusion	 coefficient	 values	 over	 the	 course	 of	 the	 NMR.	 f	 13C	 edited	 STE	 diffusion	 spectra	 of	FLN5+110	 RNC	 recorded	 at	 two	 gradient	 strengths.	 The	 translational	 diffusion	 coefficient	associated	 with	 the	 dispersed	 isoleucine	 resonances	 is	 shown	 over	 the	 time	 course	 of	 NMR	acquisition.	 The	 timeframe	 during	 which	 the	 nascent	 chain	 is	 shown	 to	 be	 attached	 to	 the	ribosome	is	indicated	by	a	grey	shaded	area.	These	data	have	been	adapted	from	ref.	1:	Figure	3	
and	Supplementary	Figures	2	and	3.			
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Supplementary Figure 1 
2D correlation spectra of FLN5 in the presence of 70S ribosomes 
a A representative region of the SOFAST 2D correlation spectrum overlay of 5 μM 15N-labelled FLN5 in the absence (red) 
and presence (cyan) of 5 μM 70S ribosomes. b The relative intensities of an equimolar sample of FLN5 and 70S 
ribosomes (5 µM) vs. FLN5 alone (5 µM), plotted against primary sequence, shows that the intensities of FLN5 
resonances remain unchanged in the presence of ribosomes, making it a tractable system for RNC studies. The 
analogous study can be undertaken with the unfolded polypeptide. Errors are derived from spectral noise from one 
single measurement. Adapted from ref. 1 with permission from Nature Publishing Group. 
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Supplementary Figure 2 
Assessment of ribosome background labelling 
To assess the level of ribosomal background labelling within RNC samples, 15N/13C filtered 1H 1D (red) and 15N/13C edited 1H 1D (grey) 
spectra are collected. The intensity of the 1H envelope of bL12 resonances bound to 14N (15N/13C filtered 1H 1D) is matched by scaling 
to that of 15N-bound protons (15N/13C edited 1H 1D) in order to quantify the ratio of unlabelled to labelled species. a Intensity profiles of 
amide resonances in 15N filtered 1H 1D (red) and 15N 1H edited 1D (grey) spectra from a 15N-labelled RNC, in which the background 
labelling amounts to ~6%. b Intensity profiles of methyl resonances in 13C filtered 1H 1D (red) and 13C edited 1H 1D (grey) spectra from 
a 13C-labelled RNC. We determine that ~13% of its bL12 resonances are labelled. 
	
	
		
